Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
2.394
Zitationen
29
Autoren
2012
Jahr
Abstract
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007. The document contains chapters on definitions and classification, we now also proposed definitions for difficult to treat rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology and treatment of these two entities. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for otorhinolaryngologists. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.
Ähnliche Arbeiten
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
2020 · 5.398 Zit.
A colorimetric method for the determination of glucosamine and chondrosamine
1933 · 1.775 Zit.
Psychometric validity of the 22‐item Sinonasal Outcome Test
2009 · 1.536 Zit.
Staging in rhinosinusitus.
1993 · 1.518 Zit.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
2019 · 1.399 Zit.
Autoren
- W. J. Fokkens
- Valerie J. Lund
- J Mullol
- Claus Bachert
- Isam Alobid
- Fuad M. Baroody
- Noah Cohen
- Anders Cervin
- Richard Douglas
- Philippe Gevaert
- C. Georgalas
- H. Goossens
- Richard J. Harvey
- Peter W. Hellings
- Claire Hopkins
- Nick S. Jones
- Guy Joos
- Livije Kalogjera
- Benjamin Kern
- M. L. Kowalski
- David Price
- Herbert Riechelmann
- Rodney J. Schlosser
- Brent A. Senior
- Mike Thomas
- Е. Тоскала
- Richard Louis Voegels
- D.Y. Wang
- Peter‐John Wormald
Institutionen
- Amsterdam UMC Location University of Amsterdam(NL)
- University of Amsterdam(NL)
- Royal National Throat Nose and Ear Hospital(GB)
- Biomedical Research Institute(US)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)
- Ghent University Hospital(BE)
- University of Chicago(US)
- University of Pennsylvania(US)
- California University of Pennsylvania(US)
- Auckland City Hospital(NZ)
- University of Antwerp(BE)
- UNSW Sydney(AU)
- KU Leuven(BE)
- St. Thomas Hospital(CA)
- St Thomas' Hospital(GB)
- University of Nottingham(GB)
- University of Zagreb(HR)
- Northwestern University(US)
- Medical University of Lodz(PL)
- University of Aberdeen(GB)
- Innsbruck Medical University(AT)
- Medical University of South Carolina(US)
- University of Southampton(GB)
- Children's Hospital of Philadelphia(US)
- Universidade de São Paulo(BR)
- National University of Singapore(SG)
- Flinders University(AU)
- The University of Adelaide(AU)